Jingyang Zhong, Ph.D. - Publications

Affiliations: 
2013 Neuroscience University of Southern California, Los Angeles, CA, United States 

79 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Wang HL, Cucchetti A, Zhong JH, Ye XP, Gu JH, Ma L, Peng NF, Li LQ. Should hepatic resection be recommended to patients with hepatocellular carcinoma and portal vein invasion? Journal of Hepatology. PMID 27475616 DOI: 10.1016/j.jhep.2016.07.022  0.64
2016 Zhong JH, Ma L, Xiang BD, Li LQ, Yang T. We're Still in an Update Process of the BCLC System. Annals of Surgery. PMID 27455159 DOI: 10.1097/SLA.0000000000001922  0.64
2016 Zhong JH, Yang T, Xiang BD, Li LQ, Ma L. Antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after surgery: A comment for moving forward. World Journal of Hepatology. 8: 605-606. PMID 27168873 DOI: 10.4254/wjh.v8.i13.605  0.64
2016 Zhu SL, Zhong JH, Gong WF, Li H, Li LQ. Association of the miR-196a2 C>T and miR-499 A>G polymorphisms with hepatitis B virus-related hepatocellular carcinoma risk: an updated meta-analysis. Oncotargets and Therapy. 9: 2111-9. PMID 27143913 DOI: 10.2147/OTT.S96738  0.64
2016 Hu S, Chen M, Wang Y, Wang Z, Pei Y, Fan R, Liu X, Wang L, Zhou J, Zheng S, Zhang T, Lin Y, Zhang M, Tao R, Zhong J. mTOR Inhibition Attenuates Dextran Sulfate Sodium-Induced Colitis by Suppressing T Cell Proliferation and Balancing TH1/TH17/Treg Profile. Plos One. 11: e0154564. PMID 27128484 DOI: 10.1371/journal.pone.0154564  0.44
2016 Chi X, Niu Y, Cheng M, Liu X, Feng Y, Zheng F, Fan J, Li X, Jin Q, Zhong J, Li YP, Yang W. Identification of a Potent and Broad-Spectrum Hepatitis C Virus Fusion Inhibitory Peptide from the E2 Stem Domain. Scientific Reports. 6: 25224. PMID 27121372 DOI: 10.1038/srep25224  0.44
2016 Mo HY, Zhong JH. Comment on stereotactic body radiation therapy for small primary or recurrent hepatocellular carcinoma. Journal of Surgical Oncology. 113: 715. PMID 27115837 DOI: 10.1002/jso.24192  0.64
2016 Mo HY, Zhong JH, Li LQ. Comment on tumor size as a prognostic factor for solitary HCC after resection. Journal of Surgical Oncology. 113: 593. PMID 27110702 DOI: 10.1002/jso.24173  0.64
2016 Liu D, Zhang J, Liu X, Wang W, Liu D, Teng Z, Fang X, Tan Z, Tang S, Yang J, Zhong J, Zhang Z. Fine mapping and RNA-Seq unravels candidate genes for a major QTL controlling multiple fiber quality traits at the T1 region in upland cotton. Bmc Genomics. 17: 295. PMID 27094760 DOI: 10.1186/s12864-016-2605-6  0.44
2016 Mo HY, Zhong JH, Qin HG. Association of blood transfusion during resection for hepatocellular carcinoma with postoperative recurrence and overall survival: a cautionary comment. Journal of Hepatology. PMID 27057989 DOI: 10.1016/j.jhep.2016.01.042  0.64
2016 Wang YY, Zhong JH, Su ZY, Huang JF, Lu SD, Xiang BD, Ma L, Qi LN, Ou BN, Li LQ. Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma. The British Journal of Surgery. PMID 27005482 DOI: 10.1002/bjs.10095  0.64
2016 Matsushita K, Yang HC, Mysore MM, Zhong J, Shyr Y, Ma LJ, Fogo AB. Effects of combination PPARγ agonist and angiotensin receptor blocker on glomerulosclerosis. Laboratory Investigation; a Journal of Technical Methods and Pathology. PMID 26999660 DOI: 10.1038/labinvest.2016.42  0.4
2016 Zhao Y, Liang Y, Liu Y, Zhang X, Hu X, Tu S, Wu A, Zhang C, Zhong J, Zhao S, Liu X, Tu K. Isolation of Broad-specificity Domain Antibody from Phage Library for Development of Pyrethroid Immunoassay. Analytical Biochemistry. PMID 26965575 DOI: 10.1016/j.ab.2016.02.020  0.44
2016 Mo HY, You XM, Xiang BD, Li LQ, Zhong JH. Are We Sure that Blood Transfusion is Associated with Recurrence of Hepatocellular Carcinoma After Hepatectomy? World Journal of Surgery. PMID 26902634 DOI: 10.1007/s00268-016-3464-7  0.64
2016 Guo J, Pan LH, Li YX, Yang XD, Li LQ, Zhang CY, Zhong JH. Efficacy of triclosan-coated sutures for reducing risk of surgical site infection in adults: a meta-analysis of randomized clinical trials. The Journal of Surgical Research. 201: 105-17. PMID 26850191 DOI: 10.1016/j.jss.2015.10.015  0.64
2016 Lu SD, Wang YY, Peng NF, Peng YC, Zhong JH, Qin HG, Xiang BD, You XM, Ma L, Li LQ. Preoperative Ratio of Neutrophils to Lymphocytes Predicts Postresection Survival in Selected Patients With Early or Intermediate Stage Hepatocellular Carcinoma. Medicine. 95: e2722. PMID 26844516 DOI: 10.1097/MD.0000000000002722  0.64
2016 Xia Z, Wang P, Liu X, Liu T, Yan Y, Yan J, Zhong J, Sun G, He D. Tumor Penetrating Peptide Modified DNA Tetrahedron for Targeting Drug Delivery. Biochemistry. PMID 26789283 DOI: 10.1021/acs.biochem.5b01181  0.44
2016 Wu LC, Gong WF, Zhong JH. A premature proposal for new liver cancer seromarkers. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. PMID 26758434 DOI: 10.1007/s13277-016-4801-z  0.64
2016 Li MY, Hu XX, Zhong JH, Chen LL, Lin YX. Therapeutic role of systematic lymphadenectomy in early-stage endometrial cancer: A systematic review Oncology Letters. 11: 3849-3857. DOI: 10.3892/ol.2016.4467  0.64
2016 Li K, Zhang J, Liu Y, Barati M, Liu Z, Zhong J, Su B, Wei M, Wang G, Yang T. Graphitization of Coke and Its Interaction with Slag in the Hearth of a Blast Furnace Metallurgical and Materials Transactions B: Process Metallurgy and Materials Processing Science. 1-8. DOI: 10.1007/s11663-015-0574-9  0.48
2016 Zhu SL, Gong WF, Han CY, Li H, Li LQ, Zhong JH. Association of two common microRNA gene polymorphisms with risk of hepatocellular carcinoma: A meta-analysis International Journal of Clinical and Experimental Medicine. 9: 535-543.  0.64
2015 Wang YY, Zhong JH, Qin HG, Li LQ. Comment on: Surgical resection versus transarterial chemoembolization for BCLC stage C hepatocellular carcinoma. Journal of Surgical Oncology. 112: 907-8. PMID 26768513 DOI: 10.1002/jso.24066  0.64
2015 Liu L, Zhang QS, Pan LH, Zhong JH, Qin ZM, Wang YY, Qin HG, Gong WF, Qi LN, Xiang BD, Li LQ. Subclassification of patients with solitary hepatocellular carcinoma based on post-hepatectomy survival: a large retrospective study. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. PMID 26561470 DOI: 10.1007/s13277-015-4387-x  0.64
2015 You XM, Mo XS, Ma L, Zhong JH, Qin HG, Lu Z, Xiang BD, Wu FX, Zhao XH, Tang J, Pang YH, Chen J, Li LQ. Randomized Clinical Trial Comparing Efficacy of Simo Decoction and Acupuncture or Chewing Gum Alone on Postoperative Ileus in Patients With Hepatocellular Carcinoma After Hepatectomy. Medicine. 94: e1968. PMID 26559269 DOI: 10.1097/MD.0000000000001968  0.64
2015 Zhong JH, Xiang BD, Li LQ. Comment on a meta-analysis comparing hepatic resection or transarterial chemoembolization as initial treatment for hepatocellular carcinoma. Drug Design, Development and Therapy. 9: 5623-4. PMID 26508836 DOI: 10.2147/DDDT.S96547  0.64
2015 Jiang JH, Xiang BD, Li LQ, Zhong JH. Postoperative antiviral therapy with nucleos(t)ide analogs for patients with hepatitis B virus-related hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology. PMID 26500197 DOI: 10.1016/j.clinre.2015.09.002  0.64
2015 Zhong JH. The STORM trial and beyond: narrowing the horizon of adjuvant sorafenib for postoperative hepatocellular carcinoma. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. PMID 26499777 DOI: 10.1007/s13277-015-4279-0  0.64
2015 Deng L, Yang C, Li LQ, Zhong JH. Hepatic Resection Improves Long-Term Survival of Patients with Large and/or Multinodular Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. PMID 26464016 DOI: 10.1007/s11605-015-2965-2  0.64
2015 Lu SC, Zhong JH, Tan JT, Tang HL, Liu XG, Xiang BD, Li LQ, Peng T. Association between COX-2 gene polymorphisms and risk of hepatocellular carcinoma development: a meta-analysis. Bmj Open. 5: e008263. PMID 26438136 DOI: 10.1136/bmjopen-2015-008263  0.64
2015 Zhong JH, Deng L, Tan JT. Adjuvant immunotherapy for postoperative hepatocellular carcinoma. Gastroenterology. PMID 26433111 DOI: 10.1053/j.gastro.2015.06.056  0.64
2015 Xie ZB, Zhu SL, Peng YC, Chen J, Wang XB, Ma L, Bai T, Xiang BD, Li LQ, Zhong JH. Postoperative hepatitis B virus reactivation and surgery-induced immunosuppression in patients with hepatitis B-related hepatocellular carcinoma. Journal of Surgical Oncology. PMID 26421419 DOI: 10.1002/jso.24044  0.64
2015 Yuan BH, Yuan WP, Li RH, Xiang BD, Gong WF, Li LQ, Zhong JH. Propensity score-based comparison of hepatic resection and transarterial chemoembolization for patients with advanced hepatocellular carcinoma. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. PMID 26383523 DOI: 10.1007/s13277-015-4091-x  0.64
2015 Zhong JH, You XM, Lu SD, Wang YY, Xiang BD, Ma L, Wu FX, Yuan WP, Chen Y, Li LQ. Historical Comparison of Overall Survival after Hepatic Resection for Patients With Large and/or Multinodular Hepatocellular Carcinoma. Medicine. 94: e1426. PMID 26334902 DOI: 10.1097/MD.0000000000001426  0.64
2015 Zhu SL, Zhong JH, Ke Y, Ma L, You XM, Li LQ. Efficacy of hepatic resection vs transarterial chemoembolization for solitary huge hepatocellular carcinoma. World Journal of Gastroenterology : Wjg. 21: 9630-7. PMID 26327771 DOI: 10.3748/wjg.v21.i32.9630  0.64
2015 Lu HF, Yuan WP, Li M, Huang Q, Liu JP, Li LQ, Zhong JH. Properly assessing CD133 as a risk factor for poor prognosis in patients with hepatocellular carcinoma after resection. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. PMID 26025114 DOI: 10.1007/s13277-015-3612-y  0.64
2015 Deng L, Qin HG, Yang C, Zhong JH. Possible associations between ascites and vascular invasion in patients with hepatocellular carcinoma. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. PMID 25934340 DOI: 10.1007/s13277-015-3521-0  0.64
2015 Jiang JH, Guo Z, Lu HF, Wang XB, Yang HJ, Yang FQ, Bao SY, Zhong JH, Li LQ, Yang RR, Xiang BD. Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: propensity score analysis. World Journal of Gastroenterology : Wjg. 21: 4627-34. PMID 25914472 DOI: 10.3748/wjg.v21.i15.4627  0.64
2015 Zhong JH, Xiang BD, Li LQ. Letter: pre- and post-operative anti-viral therapy is important for patients with hepatitis B virus-related hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics. 41: 789-90. PMID 25781042 DOI: 10.1111/apt.13098  0.64
2015 Zhong JH, Rodríguez AC, Ke Y, Wang YY, Wang L, Li LQ. Hepatic resection as a safe and effective treatment for hepatocellular carcinoma involving a single large tumor, multiple tumors, or macrovascular invasion. Medicine. 94: e396. PMID 25621684 DOI: 10.1097/MD.0000000000000396  0.64
2015 Xie ZB, Wang XB, Peng YC, Zhu SL, Ma L, Xiang BD, Gong WF, Chen J, You XM, Jiang JH, Li LQ, Zhong JH. Systematic review comparing the safety and efficacy of conventional and drug-eluting bead transarterial chemoembolization for inoperable hepatocellular carcinoma. Hepatology Research : the Official Journal of the Japan Society of Hepatology. 45: 190-200. PMID 25388603 DOI: 10.1111/hepr.12450  0.64
2015 Zhong JH, Ke Y, Wang YY, Li LQ. Liver resection for patients with hepatocellular carcinoma and macrovascular invasion, multiple tumours, or portal hypertension. Gut. 64: 520-1. PMID 25187522 DOI: 10.1136/gutjnl-2014-308139  0.64
2015 Yang XD, Pan LH, Wang L, Ke Y, Cao J, Yang C, Zhong JH, Luo W, Guo J, Li LQ. Systematic review of single large and/or multinodular hepatocellular carcinoma: Surgical resection improves survival Asian Pacific Journal of Cancer Prevention. 16: 5541-5547. DOI: 10.7314/APJCP.2015.16.13.5541  0.64
2015 Wei L, You X, Li L, Zhong J. Hepatic resection for hepatocellular carcinoma involving a single large tumor, multiple tumors or macrovascular invasion National Medical Journal of China. 95: 3115-3118. DOI: 10.3760/cma.j.issn.0376-2491.2015.38.010  0.64
2015 Zhu SL, Zhong JH, Ke Y, Ma L, You XM, Li LQ. Efficacy of hepatic resection vs transarterial chemoembolization for solitary huge hepatocellular carcinoma World Journal of Gastroenterology. 21: 9630-9637. DOI: 10.3748/wjg.v21.i32.9630  0.64
2015 Zhu SL, Chen J, Li H, Li LQ, Zhong JH. Efficacy of hepatic resection for huge (≥ 10 cm) hepatocellular carcinoma: Good prognosis associated with the uninodular subtype International Journal of Clinical and Experimental Medicine. 8: 20581-20588.  0.64
2014 Zhu SL, Ke Y, Peng YC, Ma L, Li H, Li LQ, Zhong JH. Comparison of long-term survival of patients with solitary large hepatocellular carcinoma of BCLC stage A after liver resection or transarterial chemoembolization: a propensity score analysis. Plos One. 9: e115834. PMID 25541684 DOI: 10.1371/journal.pone.0115834  0.64
2014 Wang YY, Huang S, Zhong JH, Ke Y, Guo Z, Liu JQ, Ma L, Li H, Ou BN, Li LQ. Impact of diabetes mellitus on the prognosis of patients with hepatocellular carcinoma after curative hepatectomy. Plos One. 9: e113858. PMID 25436613 DOI: 10.1371/journal.pone.0113858  0.64
2014 Zhong JH. Nucleos(t)ide analogue therapy for HBV-related HCC after hepatic resection: clinical benefits and unanswered questions Tumor Biology. 35: 12779-12784. PMID 25431264 DOI: 10.1007/s13277-014-2881-1  0.64
2014 Ke Y, Wang L, Li LQ, Zhong JH. Nucleos(t)ide analogues to treat hepatitis B virus-related hepatocellular carcinoma after radical resection. World Journal of Hepatology. 6: 652-9. PMID 25276281 DOI: 10.4254/wjh.v6.i9.652  0.64
2014 Zhong JH, Li H, Xiao N, Ye XP, Ke Y, Wang YY, Ma L, Chen J, You XM, Zhang ZY, Lu SD, Li LQ. Hepatic resection is safe and effective for patients with hepatocellular carcinoma and portal hypertension. Plos One. 9: e108755. PMID 25268959 DOI: 10.1371/journal.pone.0108755  0.64
2014 Zhong JH, Wu FX, Li H. Hepatic resection associated with good survival for selected patients with multinodular hepatocellular carcinoma. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 35: 8355-8. PMID 25195949 DOI: 10.1007/s13277-014-2571-z  0.64
2014 Zhong JH, Zhong QL, Li LQ, Li H. Adjuvant and chemopreventive therapies for resectable hepatocellular carcinoma: a literature review Tumor Biology. 35: 9459-9468. PMID 25119592 DOI: 10.1007/s13277-014-2443-6  0.64
2014 Xie ZB, Ma L, Wang XB, Bai T, Ye JZ, Zhong JH, Li LQ. Transarterial embolization with or without chemotherapy for advanced hepatocellular carcinoma: a systematic review. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 35: 8451-9. PMID 25038916 DOI: 10.1007/s13277-014-2340-z  0.64
2014 Gong WF, He W, Zhang QM, Xiang BD, Ma L, Huang S, Bai T, Zhong JH, Li LQ. Try113His and His139Arg polymorphisms in the microsomal epoxide hydrolase gene are not associated with risk of breast cancer. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 35: 8087-93. PMID 24840637 DOI: 10.1007/s13277-014-2084-9  0.64
2014 Guo Z, Zhong JH, Jiang JH, Zhang J, Xiang BD, Li LQ. Comparison of survival of patients with BCLC stage a hepatocellular carcinoma after hepatic resection or transarterial chemoembolization: A propensity score-based analysis Annals of Surgical Oncology. 21: 3069-3076. PMID 24728740 DOI: 10.1245/s10434-014-3704-8  0.64
2014 Zhong JH, Ma L, Li LQ. Postoperative therapy options for hepatocellular carcinoma Scandinavian Journal of Gastroenterology. 49: 649-661. PMID 24716523 DOI: 10.3109/00365521.2014.905626  0.64
2014 Zhong JH, Ke Y, Gong WF, Xiang BD, Ma L, Ye XP, Peng T, Xie GS, Li LQ. Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma. Annals of Surgery. 260: 329-40. PMID 24096763 DOI: 10.1097/SLA.0000000000000236  0.64
2014 Meng J, Zhong J, Zhang H, Zhong W, Huang Z, Jin Y, Xu J. Pre-, peri-, and postoperative oral administration of branched-chain amino acids for primary liver cancer patients for hepatic resection: a systematic review. Nutrition and Cancer. 66: 517-22. PMID 24033366 DOI: 10.1080/01635581.2013.780628  0.64
2014 Liang Y, Ke Y, Zhong J, Guo Z, Jiang J, Xiang B. Thymosin alpha 1 for patients with hepatocellular carcinoma after radical hepatectomy Chinese Journal of Clinical Oncology. 41: 925-929. DOI: 10.3969/j.issn.1000-8179.20132118  0.64
2014 Ke Y, Zhong J, Guo Z, Liang Y, Li L, Xiang B. Comparison liver resection with transarterial chemoembolization for Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma patients on long-term survival after SPSS propensity score matching National Medical Journal of China. 94: 747-750. DOI: 10.3760/cma.j.issn.0376-2491.2014.10.007  0.64
2014 Zhong JH, Xiang BD, Gong WF, Ke Y, Mo QG, Ma L, Liu X, Li LQ. Correction: Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization (PLoS ONE) Plos One. 9. DOI: 10.1371/annotation/32a8c7e3-5efc-478b-b374-c8cbfd1d3968  0.64
2014 Liang YR, Huang SH, Bao SY, Guo Z, Zhong JH, Jiang JH, Zeng LX, Qin X, Xiang BD. Hepatic inflammatory myofibroblastic tumors: Analysis of 24 cases World Chinese Journal of Digestology. 2952-2956. DOI: 10.11569/wcjd.v22.i20.2952  0.64
2013 Ke Y, Ma L, You XM, Huang SX, Liang YR, Xiang BD, Li LQ, Zhong JH. Antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after radical hepatectomy. Cancer Biology & Medicine. 10: 158-64. PMID 24379991 DOI: 10.7497/j.issn.2095-3941.2013.03.006  0.64
2013 Zhong JH, Rodríguez AC, Yang NN, Li LQ. Methylenetetrahydrofolate Reductase Gene Polymorphism and Risk of Type 2 Diabetes Mellitus Plos One. 8. PMID 24023947 DOI: 10.1371/journal.pone.0074521  0.64
2013 Zhong JH, Xiang BD, Gong WF, Ke Y, Mo QG, Ma L, Liu X, Li LQ. Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization. Plos One. 8: e68193. PMID 23874536 DOI: 10.1371/journal.pone.0068193  0.64
2013 Zhong JH, Zhang ZM, Li LQ. mEH Tyr113His polymorphism and the risk of ovarian cancer development. Journal of Ovarian Research. 6: 40. PMID 23742121 DOI: 10.1186/1757-2215-6-40  0.64
2013 Gong WF, Zhong JH, Xiang BD, Ma L, You XM, Zhang QM, Li LQ. Single nucleotide polymorphism 8q24 rs13281615 and risk of breast cancer: meta-analysis of more than 100,000 cases. Plos One. 8: e60108. PMID 23565189 DOI: 10.1371/journal.pone.0060108  0.64
2013 Zhong JH, Mo XS, Xiang BD, Yuan WP, Jiang JF, Xie GS, Li LQ. Postoperative Use of the Chemopreventive Vitamin K2 Analog in Patients with Hepatocellular Carcinoma Plos One. 8. PMID 23505456 DOI: 10.1371/journal.pone.0058082  0.64
2013 Zhong JH, Xiang BD, Ma L, You XM, Li LQ, Xie GS. Meta-analysis of microsomal epoxide hydrolase gene polymorphism and risk of hepatocellular carcinoma. Plos One. 8: e57064. PMID 23451147 DOI: 10.1371/journal.pone.0057064  0.64
2013 Zhu M, Liang R, Pan LH, Huang B, Qian W, Zhong JH, Zheng WW, Li CL. Zoledronate for metastatic bone disease and pain: a meta-analysis of randomized clinical trials. Pain Medicine (Malden, Mass.). 14: 257-64. PMID 23279447 DOI: 10.1111/pme.12016  0.64
2013 Ke Y, Zhong J, You X, Huang S, Liang Y, Xiang B, Li L. Antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after radical hepatectomy Chinese Journal of Clinical Oncology. 40: 1184-1188. DOI: 10.3969/j.issn.1000-8179.20131131  0.64
2012 Zhong JH, You XM, Gong WF, Ma L, Zhang Y, Mo QG, Wu LC, Xiao J, Li LQ. Epidermal growth factor gene polymorphism and risk of hepatocellular carcinoma: a meta-analysis. Plos One. 7: e32159. PMID 22403631 DOI: 10.1371/journal.pone.0032159  0.64
2012 Zhong JH, Li H, Li LQ, You XM, Zhang Y, Zhao YN, Liu JY, Xiang BD, Wu GB. Adjuvant therapy options following curative treatment of hepatocellular carcinoma: a systematic review of randomized trials. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 38: 286-95. PMID 22281155 DOI: 10.1016/j.ejso.2012.01.006  0.64
2012 Zhong JH, Ma L, Wu LC, Zhao W, Yuan WP, Wu FX, Zhang ZM, Huang S, You XM, Li LQ. Adoptive immunotherapy for postoperative hepatocellular carcinoma: a systematic review. International Journal of Clinical Practice. 66: 21-7. PMID 22171902 DOI: 10.1111/j.1742-1241.2011.02814.x  0.64
2012 Liu X, Li L, Xiang B, Ma L, Zhong J, You X. Efficacy of hepatic resection and transarterial chemoembolization for stage B hepatocellular carcinoma in the Barcelona Clinic Liver Cancer classification Chinese Journal of Clinical Oncology. 39: 1225-1228. DOI: 10.3969/j.issn.1000-8179.2012.16.023  0.64
2011 Zhong JH, Li le Q, Wu LC. Lamivudine with or without adefovir dipivoxil for postoperative hepatocellular carcinoma. The Cochrane Database of Systematic Reviews. CD008713. PMID 22161435 DOI: 10.1002/14651858.CD008713.pub2  0.64
2011 Zhong JH, Ma L, Li LQ, Ru HM, Zhao YN. Adjuvant imatinib for gastrointestinal stromal tumors: The current situation and problems Scandinavian Journal of Gastroenterology. 46: 645-651. PMID 21271901 DOI: 10.3109/00365521.2011.551884  0.64
2011 Ma L, Zhong JH, Li LQ. Postoperative adjuvant adoptive immunotherapy for hepatocellular carcinoma: A Meta-analysis Chinese Journal of Cancer Prevention and Treatment. 18: 1551-1555.  0.64
2010 Zhong JH, Li LQ. Postoperative adjuvant transarterial chemoembolization for participants with hepatocellular carcinoma: A meta-analysis Hepatology Research. 40: 943-953. DOI: 10.1111/j.1872-034X.2010.00710.x  0.64
Show low-probability matches.